Total Payments
$16,119
2024 Payments
$1,131
Companies
70
Transactions
748
Medicare Patients
6,201
Medicare Billing
$475,391
Payment Breakdown by Category
Food & Beverage$15,925 (98.8%)
Education$194.62 (1.2%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $15,925 | 740 | 98.8% |
| Education | $194.62 | 8 | 1.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $2,438 | 154 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $2,002 | 99 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,601 | 81 | $0 (2024) |
| Mallinckrodt Enterprises LLC | $1,202 | 47 | $0 (2019) |
| Mallinckrodt Hospital Products Inc. | $799.38 | 35 | $0 (2023) |
| Mylan Specialty L.P. | $789.35 | 35 | $0 (2024) |
| PFIZER INC. | $784.84 | 39 | $0 (2024) |
| Abbott Laboratories | $646.61 | 4 | $0 (2019) |
| Insmed, Inc. | $363.43 | 19 | $0 (2024) |
| GENZYME CORPORATION | $338.07 | 13 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,131 | 50 | AstraZeneca Pharmaceuticals LP ($283.59) |
| 2023 | $1,684 | 71 | GlaxoSmithKline, LLC. ($289.19) |
| 2022 | $1,640 | 82 | GlaxoSmithKline, LLC. ($209.74) |
| 2021 | $1,919 | 92 | GlaxoSmithKline, LLC. ($382.16) |
| 2020 | $1,778 | 96 | Mallinckrodt Hospital Products Inc. ($364.26) |
| 2019 | $2,553 | 118 | Boehringer Ingelheim Pharmaceuticals, Inc. ($443.56) |
| 2018 | $2,399 | 109 | Mallinckrodt LLC ($397.44) |
| 2017 | $3,015 | 130 | GlaxoSmithKline, LLC. ($521.95) |
All Payment Transactions
748 individual payment records from CMS Open Payments — Page 1 of 30
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $18.17 | General |
| Category: Oncology | ||||||
| 12/17/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $24.50 | General |
| Category: Immunology | ||||||
| 12/11/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $19.65 | General |
| Category: IMMUNOLOGY | ||||||
| 11/26/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $25.32 | General |
| Category: RESPIRATORY | ||||||
| 11/14/2024 | Nevro Corp. | Senza (Device) | Food and Beverage | In-kind items and services | $13.98 | General |
| Category: Spinal Cord Stimulator | ||||||
| 11/13/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $21.98 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/12/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $26.65 | General |
| Category: Immunology | ||||||
| 11/07/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $125.03 | General |
| Category: Respiratory | ||||||
| 11/07/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $18.36 | General |
| Category: Respiratory | ||||||
| 10/24/2024 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Food and Beverage | In-kind items and services | $21.16 | General |
| Category: Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | ||||||
| 10/23/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $18.28 | General |
| Category: Respiratory | ||||||
| 10/17/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $22.58 | General |
| Category: RESPIRATORY | ||||||
| 10/01/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $32.40 | General |
| Category: Immunology | ||||||
| 09/26/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 | Food and Beverage | In-kind items and services | $19.61 | General |
| Category: VACCINE | ||||||
| 09/24/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $18.99 | General |
| Category: Respiratory | ||||||
| 09/18/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $14.83 | General |
| Category: Oncology | ||||||
| 09/17/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $32.35 | General |
| Category: Immunology | ||||||
| 09/17/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $15.09 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 09/12/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $25.61 | General |
| Category: Respiratory | ||||||
| 09/12/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $20.70 | General |
| Category: Diabetes | ||||||
| 09/10/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $18.70 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 09/04/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $23.41 | General |
| Category: RESPIRATORY | ||||||
| 08/21/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $27.50 | General |
| Category: Immunology | ||||||
| 08/20/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $17.63 | General |
| Category: RESPIRATORY | ||||||
| 08/07/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $15.43 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 1,225 | 1,924 | $264,900 | $92,414 |
| 2022 | 15 | 1,439 | 2,104 | $277,765 | $92,479 |
| 2021 | 18 | 1,707 | 2,967 | $289,722 | $141,658 |
| 2020 | 19 | 1,830 | 3,698 | $336,176 | $148,839 |
Total Patients
6,201
Total Services
10,693
Medicare Billing
$475,391
Procedure Codes
76
All Medicare Procedures & Services
76 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 290 | 737 | $110,550 | $40,371 | 36.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 151 | 251 | $50,200 | $20,659 | 41.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 55 | 55 | $11,000 | $7,043 | 64.0% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2023 | 118 | 121 | $18,150 | $5,327 | 29.3% |
| 94726 | Test to determine lung volumes using sensors | Office | 2023 | 118 | 121 | $12,100 | $5,151 | 42.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 79 | 79 | $19,750 | $4,045 | 20.5% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2023 | 118 | 123 | $24,600 | $3,718 | 15.1% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 11 | 11 | $2,860 | $2,803 | 98.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 158 | 299 | $1,535 | $1,472 | 95.9% |
| 90756 | Influenza vaccine, quadrivalent derived from cell cultures | Office | 2023 | 17 | 17 | $595.00 | $539.24 | 90.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 17 | 17 | $510.00 | $499.80 | 98.0% |
| 94726 | Test to determine lung volumes using sensors | Facility | 2023 | 27 | 27 | $2,700 | $247.26 | 9.2% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Facility | 2023 | 27 | 27 | $5,400 | $212.68 | 3.9% |
| 94729 | Test to examine how well the lungs exchange gases | Facility | 2023 | 27 | 27 | $4,050 | $184.86 | 4.6% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 12 | 12 | $900.00 | $142.32 | 15.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 349 | 794 | $119,100 | $41,083 | 34.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 155 | 221 | $44,200 | $18,643 | 42.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 68 | 68 | $13,600 | $7,794 | 57.3% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2022 | 129 | 130 | $19,500 | $5,632 | 28.9% |
| 94726 | Test to determine lung volumes using sensors | Office | 2022 | 130 | 131 | $13,100 | $5,163 | 39.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 89 | 89 | $22,250 | $4,644 | 20.9% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2022 | 132 | 133 | $26,600 | $3,678 | 13.8% |
| 71046 | X-ray of chest, 2 views | Office | 2022 | 49 | 62 | $4,650 | $1,624 | 34.9% |
| 90756 | Influenza vaccine, quadrivalent derived from cell cultures | Office | 2022 | 29 | 30 | $1,050 | $891.10 | 84.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 28 | 28 | $840.00 | $826.20 | 98.4% |
About Dr. Howard Braver, M.D
Dr. Howard Braver, M.D is a Pulmonary Disease healthcare provider based in Hollywood, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/04/2006. The National Provider Identifier (NPI) number assigned to this provider is 1184672123.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Howard Braver, M.D has received a total of $16,119 in payments from pharmaceutical and medical device companies, with $1,131 received in 2024. These payments were reported across 748 transactions from 70 companies. The most common payment nature is "Food and Beverage" ($15,925).
As a Medicare-enrolled provider, Braver has provided services to 6,201 Medicare beneficiaries, totaling 10,693 services with total Medicare billing of $475,391. Data is available for 4 years (2020–2023), covering 76 distinct procedure/service records.
Ad
Practice Information
- Specialty Pulmonary Disease
- Other Specialties Internal Medicine
- Location Hollywood, FL
- Active Since 05/04/2006
- Last Updated 11/17/2022
- Taxonomy Code 207RP1001X
- Entity Type Individual
- NPI Number 1184672123
Products in Payments
- ACTHAR (Biological) $2,002
- TRELEGY ELLIPTA (Drug) $1,351
- OFEV (Drug) $967.09
- SYMBICORT (Drug) $722.89
- Yupelri (Drug) $523.56
- ANORO (Drug) $430.47
- DUPIXENT (Biological) $408.42
- PURIFIED CORTROPHIN GEL (Drug) $397.06
- Arikayce (Drug) $363.43
- ELIQUIS (Drug) $360.80
- Confirm Rx (Device) $335.02
- BREO (Drug) $320.22
- CRT-Ds (Device) $311.59
- BREZTRI (Drug) $300.76
- STIOLTO RESPIMAT (Drug) $262.30
- BEVESPI AEROSPHERE (Drug) $259.91
- AIRSUPRA (Drug) $250.30
- CHANTIX (Drug) $250.29
- XARELTO (Drug) $202.87
- NUCALA (Biological) $201.73
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pulmonary Disease Doctors in Hollywood
Brian Gotkin, Md, MD
Pulmonary Disease — Payments: $10,604
Pulmonary Disease $10,604
Jyoti Shah
Pulmonary Disease — Payments: $4,537
Pulmonary Disease $4,537
Steven Gittler, Md, MD
Pulmonary Disease — Payments: $3,503
Pulmonary Disease $3,503
Boris Betancourt, Md, MD
Pulmonary Disease — Payments: $1,342
Pulmonary Disease $1,342
Ronald Gup, M.d, M.D
Pulmonary Disease — Payments: $887.58
Pulmonary Disease $887.58
Sheyla Paredes Aller, Md, MD
Pulmonary Disease — Payments: $276.37
Pulmonary Disease $276.37